Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Quality Index
Shanghai Yizhong Pharmaceutical Co Ltd cash flow quality index. Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Quality Index of 1.66x as of September 2025. Operating cash flow of CN¥21.03 Million exceeds net income of CN¥12.65 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Yizhong Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Cash flow quality index of Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. Historical Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Shanghai Yizhong Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2022–2024)
Shanghai Yizhong Pharmaceutical Co Ltd cash flow quality index by year from 2022 to 2024. Year-by-year earnings quality comparison for Shanghai Yizhong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Shanghai Yizhong Pharmaceutical Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 5.65x | CN¥39.44 Million | CN¥6.98 Million | ▲ +955.3% |
| 2023 | 0.54x | CN¥86.55 Million | CN¥161.55 Million | ▼ -30.9% |
| 2022 | 0.78x | CN¥110.78 Million | CN¥142.85 Million | — |